Allogeneic

Using cells from someone other than the patient, such as healthy donors or an established iPS cell line, so that large batches can be made and stored frozen for many patients. Holding inventory becomes possible, but HLA mismatch brings risks of rejection and graft-versus-host disease, and donor eligibility and cell bank qualification become central. Japanese documents use the native term, meaning 'another person', together with the English word.